Michelle Luster

Appearances

SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS
Date
May 21, 2024
BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…
Presenter
Hashem El-Serag
Baylor College of Medicine
Speakers
Fasiha Kanwal
Michael E. DeBakey VAMC
Jing Ning
Hannah Powell
Saira Khaderi
Baylor College of Medicine
Amit Singal
UT Southwestern Medical Center
Sumeet K. Asrani
Baylor University Medical Center
Jorge Marrero
Christopher Amos
Aaron Thrift
Michelle Luster
Abeer Alsarraj
Luis Olivares
Darlene Skapura
Jenny Deng
Emad Salem
Omar Najjar
Xian Yu
Hao Duong
Michael Scheurer
Christie Ballantyne
Salma Kaochar